Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chemotherapy With or Without Bevacizumab in Resected Stage IB-IIIA NSCLC
NCT00324805Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2007
- Primary completion
- Oct 2015
- Modality
- Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 3 trial of bevacizumab in non-small cell lung cancer (NSCLC), sponsored by National Cancer Institute. Started Jul 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00324805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00324805.